Early Kidney Disease: Risks, Silent Signs, and the Tests That Matter (eGFR & uACR)

Apr 6, 2026

  • 5
  • News
  • 5
  • Early Kidney Disease: Risks, Silent Signs, and the Tests That Matter (eGFR & uACR)

Understanding kidney health can feel overwhelming, especially when symptoms are not obvious. This overview provides clear, trustworthy information so you can discuss next steps with your clinician and make informed decisions.

Who Is at Risk—and Why Screening Matters

Kidney screening is a preventive step meant to protect health before symptoms appear. It is appropriate to discuss screening if you have any of the following:

  • Diabetes (type 1 or 2)
  • High blood pressure (hypertension)
  • Heart disease or heart failure
  • Family history of kidney disease
  • Age 60 or older
  • Certain autoimmune conditions, recurrent kidney stones, or long-term use of some pain relievers (e.g., NSAIDs)

If one or more of these factors apply, consider speaking with your doctor about kidney testing and how often it should be repeated for you.

The Two Cornerstone Tests: eGFR and uACR

eGFR (estimated glomerular filtration rate)
eGFR is calculated from a blood test (serum creatinine) together with age and sex using validated equations. In everyday terms, it estimates how effectively the kidneys filter waste. Because hydration, recent illness, and medications can influence a single measurement, clinicians interpret trends over time rather than relying on one result.

uACR (urine albumin-to-creatinine ratio)
uACR is a urine test that looks for small amounts of albumin (a protein). Persistent albumin in the urine can be an early sign of kidney injury, even when eGFR appears within expected limits. Your clinician will interpret uACR alongside eGFR, medical history, and repeat testing when needed.

Why both tests are important
eGFR reflects function; uACR signals damage. Evaluating them together provides a more complete picture of current risk and future outlook than either test alone.

“No Symptoms—Do I Still Need Testing?”

Early chronic kidney disease (CKD) often causes no noticeable symptoms. When present, signs are nonspecific—such as fatigue, ankle or eyelid swelling, foamy urine, or frequent nighttime urination—and can be caused by many conditions. Objective testing is the reliable way to understand kidney health.

Interpreting Results in Plain Language

A helpful way to think about results is to place them on two axes:

  • Function (eGFR): How strong is the filter?
  • Damage (uACR): Is the filter allowing protein to pass?

For example, a person with a mildly reduced eGFR but no persistent albumin in the urine may have a different risk profile than someone with an eGFR in an expected range but ongoing albuminuria. Persistent findings typically prompt confirmation with repeat testing and a tailored plan.

Practical Steps to Protect Kidney Function

Kidney-protective care is evidence-based and achievable:

  1. Control blood pressure. Elevated pressure injures delicate kidney vessels. Lifestyle measures and medications are often required. In patients with albuminuria, ACE inhibitors or ARBs are commonly considered to reduce pressure within the kidney filter and protein loss, when clinically appropriate.
  2. Manage blood sugar. In diabetes, steady glucose control lowers kidney risk. In selected patients, newer therapies may provide additional kidney protection; treatment is individualized.
  3. Reduce dietary sodium. Less salt supports blood pressure and fluid balance. Emphasize fresh foods and limit highly processed items.
  4. Stay active and maintain a healthy weight. Regular, moderate activity supports cardiovascular health and blood-pressure control.
  5. Use pain relievers responsibly. Frequent or high-dose use of certain NSAIDs can stress the kidneys, particularly with dehydration or other risk factors. Review all medications with your clinician.
  6. Do not smoke. Smoking accelerates vascular injury, including in the kidneys.

There is no one-size-fits-all plan. Two patients with the same eGFR may need different strategies based on uACR, blood-pressure patterns, other conditions, and current therapies.

How Often to Repeat Tests

Testing intervals depend on personal risk and prior findings. Many at-risk adults benefit from periodic (often annual) eGFR and uACR screening, whereas individuals with established CKD or persistent albuminuria may need more frequent monitoring to assess response to treatment and update targets. Your clinician will set the schedule that fits your situation.

When to Consider Specialty Evaluation

Referral to a nephrologist is appropriate when:

  • Risk factors are present and screening has not been performed
  • Albumin in the urine persists on repeat testing
  • eGFR is trending downward or remains below expected levels for age and context
  • Blood or significant protein persists in the urine
  • Results are unclear and a personalized plan is needed

Early specialty input does not imply imminent dialysis or invasive procedures; it helps identify reversible causes and optimize kidney-protective care.

A Brief, Real-World Scenario

Two adults have eGFR within an expected range:

  • Person A: No persistent albumin in the urine and well-controlled blood pressure → continue periodic monitoring and healthy habits.
  • Person B: Ongoing albuminuria and variable home blood pressure → strengthen sodium reduction, optimize antihypertensive therapy, review NSAID use, and repeat testing to confirm improvement. Addressing both function and damage reduces long-term risk.

 

Key takeaway: Chronic kidney disease often begins silently. If risk factors are present, ask your clinician about both eGFR and uACR. Understanding these results together—and following a realistic plan—offers the best chance to preserve kidney function over time.